News >

Key Advances in Sarcoma Lead to More Personalized Medicine Efforts

Ellie Leick
Published: Tuesday, Mar 17, 2020

Jonathan C. Trent, MD, PhD, a professor and associate director for Clinical Research at the Sylvester Comprehensive Cancer Center, University of Miami Health Syste

Jonathan C. Trent, MD, PhD

Soft tissue sarcoma treatments have significantly advanced within the past year with new available agents, others in the pipeline, and the continued search for biomarkers to make treatment more personalized for patients, explained Jonathan C. Trent, MD, PhD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication